Hong Kong equities opened with a positive gap on Tuesday following overnight gains on Wall Street, but the momentum quickly reversed with the benchmark closing 0.39% lower. The Middle East conflict remains unresolved despite Washington's pause on airstrikes, as Iran's Revolutionary Guard claimed responsibility for missile and drone attacks on multiple US bases across Kuwait, Jordan, and Iraq, reporting "multiple American casualties." Oil prices resumed their upward trajectory with WTI crude futures advancing 2.06% to $92.881 per barrel after briefly sliding over 1% earlier, while Brent crude climbed 1.83% to $97.381 per barrel. Despite the US and Venezuela signing several oil cooperation agreements鈥攚ith Chevron Corp (NYSE: CVX) announcing a $7 billion five-year investment plan aiming to double Venezuelan output to 600,000 barrels per day by 2028鈥攖he threat of fresh US military action continues to underpin prices.

The primary domestic drag on Hong Kong markets came from a sharp appreciation of the Japanese yen, which surged to approximately 156.40 against the US dollar during trading hours, representing a 1.46% gain. This followed significant strength the prior session and accelerated amid speculation that the Bank of Japan is preparing to hike interest rates. The yen's rapid ascent raises expectations of capital repatriation to Japan, triggering broad-based selling in banking stocks. Agricultural Bank of China Ltd (HKG: 01288) fell 2.81%, a notable decline for the sector. Fortunately, insurance equities stepped in to provide support, preventing a more severe market slide.

All five A-share listed insurers鈥攎amely PICC Group (HKG: 01339), China Life Insurance Co Ltd (HKG: 02628), Ping An Insurance Group Co of China Ltd (HKG: 02318), China Pacific Insurance Group Co Ltd (HKG: 02601), and New China Life Insurance Co Ltd (HKG: 01336)鈥攈ave now disclosed their 2026 interim dividend plans following the release of half-year results. These five companies collectively intend to distribute more than RMB 39 billion in mid-year dividends, with China Pacific Insurance announcing its first-ever interim dividend. Management teams across the sector emphasized their commitment to institutionalizing regular dividend payments, aiming for sustainable long-term shareholder returns supported by stable operations. Leading performers included New China Life (HKG: 01336), PICC (HKG: 01339), and Ping An (HKG: 02318), each advancing over 2%.

Wednesday's ADP employment report showed US private sector payrolls increased by just 38,000 in August, well below the 47,000 expected and marking the lowest reading this year. According to CME FedWatch data, the probability of the Federal Reserve holding rates steady at its September meeting rose to 37.7% from 33.8% prior to the release, while odds for a 25-basis-point hike fell to 62.3% from 66.2%. Separately, on September 2, the Dutch central bank completed a redistribution of 86 tonnes of gold reserves accumulated between March and August, transferring holdings from New York and Ottawa to London. This move aims to strengthen crisis response capabilities amid geopolitical instability, reflecting concerns that US-held assets could face restrictions or trading limitations should transatlantic relations deteriorate. Gold held in London can be more readily converted to foreign exchange. Spot gold staged a V-shaped rebound back above $4,400 per ounce, while COMEX gold futures advanced over 1%. Wanguo International Gold Group Ltd (HKG: 03939) and Zijin Gold International (HKG: 02259) both surged over 7%, with Chifeng Jilong Gold Mining Co Ltd (HKG: 06693) and Lingbao Gold Group Co Ltd (HKG: 03330) climbing more than 5%.

Base metals typically move in tandem with gold. Copper simultaneously connects to power grids, new energy vehicles, energy storage, renewable power generation, data centers, AI servers, and industrial automation, while mine development cycles remain extremely lengthy. As demand expands and supply growth lags, market trading shifts from single-day headlines to structural supply-demand gaps over the medium to long term. MMG Ltd (HKG: 01208) advanced over 5%, while CMOC Group Ltd (HKG: 03993) and China Nonferrous Mining Corp Ltd (HKG: 01258) each gained more than 3%. The aluminum narrative follows similar logic, with Nanshan Aluminium International Holdings Ltd (HKG: 02610) and Innovation Industrial (HKG: 02788) both rising over 3%.

The Baltic Dry Index surged 174 points, or 5.5%, to 3,331 on September 2, hitting its highest level since December 2023. This was driven by concentrated shipping of iron ore (including incremental volumes from the Simandou mine), coal, and grain, creating substantial new cargo demand. Beneficiaries included T.S. Lines Ltd (HKG: 02510), up nearly 7%, and Pacific Basin Shipping Ltd (HKG: 02343), gaining over 5%. In the tanker segment, longer routing around the Cape of Good Hope for safety reasons extends voyage durations and effectively reduces equivalent fleet capacity. Supply-side constraints persist as new vessel deliveries remain limited and the VLCC orderbook stands at historically low levels relative to the existing fleet, ensuring tight supply dynamics over the next one to two years. COSCO SHIPPING Energy Transportation Co Ltd (HKG: 01138) advanced over 6%, while Orient Overseas International Ltd (HKG: 00316) gained over 3%.

Healthcare M&A activity continues apace. Hutchison China MediTech Ltd (HKG: 00013) announced a licensing agreement with GSK for HMPL-A830, securing an upfront payment of $110 million, development and commercialization milestones of up to $1.295 billion, and tiered royalties on net sales. GSK acquires rights outside Greater China, while HUTCHMED retains domestic rights. This first-in-class KRAS-EGFR antibody-targeted drug conjugate is expected to commence clinical development in the second half of 2026. While KRAS represents one of oncology's most sought-after targets, investors should remain cognizant of potential clinical trial failures as human data emerges. Shares surged over 14%. Other potential performers included CSPC Pharmaceutical Group Ltd (HKG: 01093) and Duality Biologics Inc (HKG: 09606), each gaining over 4%. Sino Biopharmaceutical Ltd (HKG: 01177) rose over 6% after its core subsidiary Chia Tai Tianqing received FDA clearance for an investigational new drug application for TQB6426, an innovative GPC3-targeted antibody-drug conjugate intended for advanced malignancies. Having already secured clinical trial approval in China in July, this marks dual regulatory clearance in both major pharmaceutical markets; upcoming clinical data will be closely monitored. AI-driven drug development names also advanced, with Insilico Medicine (HKG: 03696) climbing over 4%.

Tesla is scheduled to unveil its autonomous robotaxi "Cybercab" this Thursday, a launch widely expected to represent a significant breakthrough in the company's robo-taxi ambitions as it seeks to catch up with rival Waymo. This has stimulated related supply chains including domestic lidar producers. On September 2, the "China Embodied Intelligence Tier1 Industry Alliance" was formally established, jointly initiated by Xingyuan Intelligence and Lingxin Qiaoshou, bringing together more than 20 industry chain enterprises including Orbbec, FA Robotics, Fulin New Materials, and Hesai Group (HKG: 02525). The alliance covers embodied brains, dexterous hands, voice interaction, lidar, visual perception, tactile sensing, robotic arms, chassis, wireless communications, and thermal management. Its objective is to resolve hardware interface inconsistencies and transition the industry from fragmented leadership to systemic advantage. Hesai (HKG: 02525) reported ADAS lidar shipments up 87% year-on-year in H1 2026, with robotics lidar shipments jumping 165%. Its Software-as-a-Service business contributed revenue for the first time, prompting management to raise the 2026 SGI revenue guidance from RMB 100 million to RMB 200-300 million. Shares advanced over 8%. In the wire-control space, Nexteer Automotive Group Ltd (HKG: 01316) gained over 3% after Hong Kong Exchange filings revealed BlackRock increased its stake by 2.483 million shares at HK$5.0735 each on August 27, totaling approximately HK$12.6 million, lifting its holding to 152 million shares or 6.08%.

Where to Focus Next

According to a research note from Guojin Securities on the home appliance sector, current market debate over white goods manufacturers centers on the pace of demand recovery and the impact of copper and aluminum price increases on margins. On the demand side, easing high-base pressure should support sequential improvement through the second half. Home appliance retail sales fell 9.5% year-on-year in H1 2026, primarily due to the high comparison base from last year's government subsidy program. Based on historical seasonal patterns, analysts project H2 2026 home appliance retail sales to rise 7.7%, with Q3 and Q4 at -2.8% and +18.2% respectively, showing narrowing declines and clear Q4 recovery. By category, air conditioner domestic and export volumes should improve, while refrigerator and washing machine exports continue growing. On costs, the most concentrated pressure phase appears to have passed, establishing a foundation for margin recovery. Average copper and aluminum prices in Q2 2026 were up 40.0% and 45.9% year-on-year respectively, though recent copper price momentum has slowed and aluminum has eased. Looking ahead, European household air conditioning penetration stands at just 23%, and leading Chinese brands hold less than 20% combined share in Western Europe, leaving ample room for penetration gains and share expansion. With easing base effects and moderating raw material cost inflation in the second half, the sector's operational improvement trajectory is becoming clearer. Combined with institutional positioning at historical lows, white goods stocks could see simultaneous earnings and valuation repair. Key Hong Kong-listed names include Midea Group Co Ltd (HKG: 00300), Hisense Home Appliances Group Co Ltd (HKG: 00921), and Haier Smart Home Co Ltd (HKG: 06690).

Stock Pick: China Nonferrous Mining (HKG: 01258) – Convertible Bond Financing Completed, Self-Owned Copper Capacity Target Doubled

On September 2, the company completed issuance of $300 million in zero-coupon convertible bonds due 2031, listed on the Stock Exchange of Hong Kong on September 3. The initial conversion price of HK$22.18 per share represents a 29% premium to the closing price before the issue date. First-half attributable profit reached $434 million, up 64.68% year-on-year, with gross margin expanding from 32.6% to 42.4% and operating cash flow growing 98.3%. The company successfully secured interest-free financing, significantly improving its financial metrics. Even if conversion occurs, dilution remains limited. Proceeds will be fully allocated to the Luanshya No. 28 shaft sulphide project in Zambia, a $530 million investment representing one of the company's core expansion initiatives for the 15th Five-Year Plan period. First-half results hit record levels, driven by higher copper and sulphuric acid prices. In H1 2026, blister and anode copper average selling prices reached $11,932/tonne (+36.0% year-on-year), cathode copper at $11,993/tonne (+38.3%), and sulphuric acid at $370/tonne (+64.4%). These robust price gains lifted gross profit to approximately $959 million, up 68.12%. Partially offsetting factors included higher purchased concentrate costs, with single-tonne production costs for blister and anode copper rising to $8,888 (+24.8%), cathode copper costs at $4,964 (+5.6%) due to elevated third-party mine inputs, while sulphuric acid unit costs declined 19.1% to $68/tonne. The company targets doubling self-owned copper production from current levels of approximately 140,000-150,000 tonnes annually to around 300,000 tonnes by 2030. Medium-to-long-term mine copper capacity could increase by 193,000 tonnes. Project breakdown: Luanshya New Mine shallow section expected to commence production in 2027, adding around 12,000 tonnes; Gangbowu Mining's Msesa ore body targeted for late 2028 commissioning, adding 15,000 tonnes; Luanshya New Mine deep section, Chambishi Samba copper project, and Bikara project expected online in 2029, collectively contributing approximately 108,000 tonnes; Africa Southeast Ore Body Phase II targeting 2030 commissioning with 12,000 tonnes addition; and the Phase III expansion anticipated post-2032, adding 46,000 tonnes. In-progress projects are advancing smoothly with phased commissioning scheduled from 2027 to 2030. The $300 million convertible bond completed on September 2 secures funding for the Luanshya shaft expansion. The company has declared a dividend of HK$0.087154 per share, payable on September 17, 2026, maintaining its high payout ratio policy to reward shareholders and bolster confidence.